Skip to main content

CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans

 The decision of who owned the rights to a hotly disputed CRISPR gene editing patent came down in favor of the Broad Institute of MIT and Harvard today so you’d think the mood would be sour at the University of California, Berkeley, the other contender in the case. But Berkeley’s Jennifer Doudna tells TechCrunch this is a positive for her. “I’m actually delighted to know… Read More
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.